Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Overview of treatment options in multiple sclerosis.

Waubant E.

J Clin Psychiatry. 2012 Jun;73(6):e22. doi: 10.4088/JCP.11006nr2c.

2.

New options for early treatment of multiple sclerosis.

Tintoré M.

J Neurol Sci. 2009 Feb 1;277 Suppl 1:S9-S11. doi: 10.1016/S0022-510X(09)70004-8. Review.

PMID:
19200870
3.

Disease modifying drugs in multiple sclerosis: mechanisms of action and new drugs in the horizon.

Marta M, Giovannoni G.

CNS Neurol Disord Drug Targets. 2012 Aug;11(5):610-23. Review.

PMID:
22583439
4.

Choosing drug therapy for multiple sclerosis. An update.

van Oosten BW, Truyen L, Barkhof F, Polman CH.

Drugs. 1998 Oct;56(4):555-69. Review.

PMID:
9806103
5.

What is new in the treatment of multiple sclerosis?

Weinstock-Guttman B, Jacobs LD.

Drugs. 2000 Mar;59(3):401-10. Review.

PMID:
10776827
6.

Current approved options for treating patients with multiple sclerosis.

Rizvi SA, Agius MA.

Neurology. 2004 Dec 28;63(12 Suppl 6):S8-14. Review.

PMID:
15623672
7.

Clinical markers of therapeutic response to disease modifying drugs.

Pozzilli C, Prosperini L.

Neurol Sci. 2008 Sep;29 Suppl 2:S211-3. doi: 10.1007/s10072-008-0939-9. Review.

PMID:
18690494
8.

Current disease-modifying treatment of multiple sclerosis.

Derwenskus J.

Mt Sinai J Med. 2011 Mar-Apr;78(2):161-75. doi: 10.1002/msj.20239. Review.

PMID:
21425262
9.

[Recent therapeutic strategy for multiple sclerosis].

Itoyama Y.

Rinsho Shinkeigaku. 2001 Dec;41(12):1214-7. Review. Japanese.

PMID:
12235841
10.

[Multiple sclerosis: current therapies and future perspectives].

Matsushita T.

Nihon Rinsho. 2011 Nov;69(11):2077-86. Review. Japanese.

PMID:
22111333
11.

Intense immunosuppression in patients with rapidly worsening multiple sclerosis: treatment guidelines for the clinician.

Boster A, Edan G, Frohman E, Javed A, Stuve O, Tselis A, Weiner H, Weinstock-Guttman B, Khan O; Multiple Sclerosis Clinical Research Center, Department of Neurology, Wayne State University School of Medicine..

Lancet Neurol. 2008 Feb;7(2):173-83. doi: 10.1016/S1474-4422(08)70020-6. Review.

PMID:
18207115
12.
13.
14.

Concepts of induction and escalation therapy in multiple sclerosis.

Rieckmann P.

J Neurol Sci. 2009 Feb 1;277 Suppl 1:S42-5. doi: 10.1016/S0022-510X(09)70012-7. Review.

PMID:
19200866
15.

Disease-modifying drugs for the early treatment of multiple sclerosis.

Flachenecker P.

Expert Rev Neurother. 2004 May;4(3):455-63. Review.

PMID:
15853542
16.

The role of natalizumab in the treatment of multiple sclerosis.

Coyle PK.

Am J Manag Care. 2010 Jun;16(6 Suppl):S164-70. Review.

17.

Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.

Stuart WH.

Curr Med Res Opin. 2007 Jun;23(6):1199-208. Epub 2007 Apr 23. Review.

PMID:
17559719
18.

Treatment options for multiple sclerosis: current and emerging therapies.

Gawronski KM, Rainka MM, Patel MJ, Gengo FM.

Pharmacotherapy. 2010 Sep;30(9):916-27. doi: 10.1592/phco.30.9.916. Review.

PMID:
20795847
19.

How do we manage and treat a patient with multiple sclerosis at risk of tuberculosis?

Fragoso YD, Adoni T, Anacleto A, Brooks JB, Carvalho Mde J, Claudino R, Damasceno A, Ferreira ML, Gama PD, Goncalves MV, Grzesiuk AK, Matta AP, Parolin MF.

Expert Rev Neurother. 2014 Nov;14(11):1251-60. doi: 10.1586/14737175.2014.962517. Epub 2014 Sep 22. Review.

PMID:
25242167
20.

Modern multiple sclerosis treatment - what is approved, what is on the horizon.

Pilz G, Wipfler P, Ladurner G, Kraus J.

Drug Discov Today. 2008 Dec;13(23-24):1013-25. doi: 10.1016/j.drudis.2008.08.003. Epub 2008 Sep 25. Review.

PMID:
18775508

Supplemental Content

Support Center